Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov;26(46):2101020.
doi: 10.2807/1560-7917.ES.2021.26.46.2101020.

Decrease in community antibiotic consumption during the COVID-19 pandemic, EU/EEA, 2020

Collaborators, Affiliations

Decrease in community antibiotic consumption during the COVID-19 pandemic, EU/EEA, 2020

Liselotte Diaz Högberg et al. Euro Surveill. 2021 Nov.

Abstract

We present a European Union/European Economic Area-wide overview of the changes in consumption of antibacterials for systemic use (ATC J01) in the community between 2019 and 2020 as reported to the European Surveillance of Antimicrobial Consumption Network. Overall antibiotic consumption decreased by 18.3% between 2019 and 2020, the largest annual decrease in the network's two-decade history. We observed a strong association between the level of community antibiotic consumption in 2019 and the size of the decrease between 2019 and 2020.

Keywords: COVID-19; antibiotic consumption; surveillance.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None declared.

Figures

Figure 1
Figure 1
Consumption of antibacterials for systemic use (ATC group J01) in the community, population-weighted mean, by ATC group, 29 EU/EEA countries, 2016–2020
Figure 2
Figure 2
Consumption of antibacterials for systemic use (ATC group J01) in the community, EU/EEA countries, change between 2019 and 2020
Figure 3
Figure 3
Scatter plot of consumption of antibacterials for systemic use (ATC group J01) in the community in 2019 vs change between 2019 and 2020, 27 EU/EEA countries

References

    1. Ullrich A, Schranz M, Rexroth U, Hamouda O, Schaade L, Diercke M, et al. Impact of the COVID-19 pandemic and associated non-pharmaceutical interventions on other notifiable infectious diseases in Germany: An analysis of national surveillance data during week 1-2016 – week 32-2020. Lancet Reg Health Eur. 2021;6:100103. - PMC - PubMed
    1. Tomczyk S, Taylor A, Brown A, de Kraker MEA, El-Saed A, Alshamrani M, et al. Impact of the COVID-19 pandemic on the surveillance, prevention and control of antimicrobial resistance: a global survey. J Antimicrob Chemother. 2021;76(11):3045-58. 10.1093/jac/dkab300 - DOI - PMC - PubMed
    1. European Centre for Disease Prevention and Control (ECDC). Antimicrobial consumption in the EU/EEA. Annual epidemiological report 2020. Stockholm: ECDC; 2021.
    1. European Centre for Disease Prevention and Control (ECDC). TESSy, The European Surveillance System. Antimicrobial consumption (AMC) reporting protocol 2021. European Surveillance of Antimicrobial Consumption Network (ESAC-Net) surveillance data for 2020. Stockholm: ECDC; 2021. Available from: https://www.ecdc.europa.eu/sites/default/files/documents/ESAC-net-report...
    1. World Health Organization (WHO) Collaborating Centre for Drug Statistics Methodology. ATC/DDD Index 2021. WHOCC. No. 2021. Oslo: Norwegian Institute of Public Health. [Accessed: 10 Sep 2021]. Available from: https://www.whocc.no/atc_ddd_index

Substances